- Home
- NRXS vs GYRO Comparison
NRXS vs GYRO Comparison
Compare NRXS & GYRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRXS
- GYRO
- Stock Information
- Founded
- NRXS 2011
- GYRO 1946
- Country
- NRXS United States
- GYRO United States
- Employees
- NRXS N/A
- GYRO N/A
- Industry
- NRXS
- GYRO Building operators
- Sector
- NRXS
- GYRO Real Estate
- Exchange
- NRXS Nasdaq
- GYRO Nasdaq
- Market Cap
- NRXS 20.8M
- GYRO 16.9M
- IPO Year
- NRXS 2023
- GYRO N/A
- Fundamental
- Price
- NRXS $2.95
- GYRO $11.34
- Analyst Decision
- NRXS
- GYRO
- Analyst Count
- NRXS 0
- GYRO 0
- Target Price
- NRXS N/A
- GYRO N/A
- AVG Volume (30 Days)
- NRXS 6.5K
- GYRO 3.8K
- Earning Date
- NRXS 11-18-2024
- GYRO 01-01-0001
- Dividend Yield
- NRXS N/A
- GYRO N/A
- EPS Growth
- NRXS N/A
- GYRO N/A
- EPS
- NRXS N/A
- GYRO N/A
- Revenue
- NRXS $2,267,053.00
- GYRO $2,738,019.00
- Revenue This Year
- NRXS $383.16
- GYRO N/A
- Revenue Next Year
- NRXS N/A
- GYRO N/A
- P/E Ratio
- NRXS N/A
- GYRO N/A
- Revenue Growth
- NRXS N/A
- GYRO N/A
- 52 Week Low
- NRXS $1.80
- GYRO $7.65
- 52 Week High
- NRXS $3.89
- GYRO $11.38
- Technical
- Relative Strength Index (RSI)
- NRXS 48.76
- GYRO 90.99
- Support Level
- NRXS $2.62
- GYRO $7.87
- Resistance Level
- NRXS $2.97
- GYRO $8.10
- Average True Range (ATR)
- NRXS 0.14
- GYRO 0.29
- MACD
- NRXS -0.00
- GYRO 0.31
- Stochastic Oscillator
- NRXS 59.71
- GYRO 98.92
About NRXS Neuraxis Inc.
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).
About GYRO Gyrodyne LLC
Gyrodyne LLC is a United States-based limited liability company. It operates in the ownership and management of industrial and medical office buildings segment. The company leases and manages various commercial properties such as medical offices and industrial properties. The properties owned by the company include Cortlandt Manor and Flowerfield.